Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine?

dc.contributor.author	Queiro Silva, Rubén
dc.date.accessioned	2022-04-22T11:14:35Z
dc.date.available	2022-04-22T11:14:35Z
dc.date.issued	2021
dc.identifier.citation	Expert opinion on biological therapy, 21(12), p. 1539-1541 (2021); doi:10.1080/14712598.2022.1998448
dc.identifier.issn	1471-2598
dc.identifier.uri	http://hdl.handle.net/10651/63009
dc.format.extent	p. 1539-1541
dc.language.iso	eng
dc.relation.ispartof	Expert opinion on biological therapy
dc.rights	© 2021 Informa UK Limited, trading as Taylor & Francis Group
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118423396&doi=10.1080%2f14712598.2022.1998448&partnerID=40&md5=d693313cae2a4545aba65427474ebfb5
dc.title	Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine?
dc.type	journal article
dc.identifier.doi	10.1080/14712598.2022.1998448
dc.relation.publisherversion	http://dx.doi.org/10.1080/14712598.2022.1998448

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.